Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes-Reference-Cited by-同舟云学术

Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes

Published:2015 Issue:4 Volume:30 Page:521
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Min Hong Ki¹,Lee Boin²,Kwok Seung-Ki¹,Ju Ji Hyeon¹,Kim Wan-Uk¹,Park Young Min²,Park Sung-Hwan¹

Affiliation:

1. Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

2. Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Publisher

Korean Association of Internal Medicine

Link

http://synapse.koreamed.org/pdf/10.3904/kjim.2015.30.4.521

Reference40 articles.

1. 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

2. Use of Allopurinol in Slowing the Progression of Renal Disease Through Its Ability to Lower Serum Uric Acid Level

3. Drug Treatment of Hyperuricemia to Prevent Cardiovascular Outcomes

4. Severe Hypersensitivity Reactions to Allopurinol

5. The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of different doses of febuxostat compared with allopurinol in the treatment of hyperuricemia: a meta-analysis of randomized controlled trials;BMC Pharmacology and Toxicology;2023-12-14

2. Kleine Ursache – große Wirkung: Spättyp-Hauttests mit Medikamenten als Auslöser von disseminierten Rezidivexanthemen;Aktuelle Dermatologie;2022-01-17

3. Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines;Frontiers in Pharmacology;2020-09-23

4. In silico design and synthesis of targeted rutin derivatives as xanthine oxidase inhibitors;BMC Chemistry;2019-05-23

5. Update on the prevention and treatment of tumor lysis syndrome;Journal of Onco-Nephrology;2019-02